In summary, this international registry showed a rather stable disease activity in the majority of AIBD patients following COVID-19 infection. Death occurred in nine patients (13%) with a mean age of 84.3 years; 6 of the 9 patients (67%) of them died during hospitalization for COVID-19 infection. Respectively, the change in disease activity of AIBD before and after COVID-19 infection is shown in Figure 1d. 1 TABLE Reported systemic treatment for AIBD before and after COVID-19 infection. [Extracted from the article]